Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Horizon is a venture lending platform that offers structured debt products to life science and technology companies. Its team of investment and operations professionals has been providing debt capital to some of the most exciting companies for decades. The members of the Horizon team have, collectively, originated and invested more than $5 billion in venture loans to thousands of companies. The company was founded in 2003 and is headquartered in Farmington, Connecticut.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
11/5/2010
Ticker Symbol:
HRZN
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
6/2013 | Overture Networks | Debt Financing | 10M |
10/2022 | Robin Healthcare | Debt Financing | 7M |
3/2016 | ScoreBig | Debt Financing | 2M |
12/2016 | Strongbridge Biopharma | Post-IPO Debt | 40M |
3/2022 | Secure Transfusion Services | Debt Financing | 15M |
3/2010 | Enphase Energy | Venture Round | 0 |
5/2022 | Soli Organic | Debt Financing | 0 |
7/2017 | Titan Pharmaceuticals | Post-IPO Debt | 10M |
7/2014 | SpringCM | Debt Financing | 6M |
7/2015 | Bridge2 Solutions | Debt Financing | 5M |
7/2021 | RepTrak | Debt Financing | 10M |
6/2015 | Medsphere Systems | Debt Financing | 7.5M |
8/2021 | Embody | Venture Round | 11.5M |
3/2022 | Aerobiotix | Debt Financing | 10M |
7/2019 | Evelo | Post-IPO Debt | 45M |
10/2021 | Stealth BioTherapeutics | Post-IPO Debt | 25M |
8/2021 | Embody | Debt Financing | 9M |
6/2021 | LiquiGlide | Debt Financing | 8M |
2/2014 | AccuVein | Debt Financing | 8M |
1/2016 | Digital Signal | Debt Financing | 12M |
1/2022 | Interior Define | Debt Financing | 30M |
8/2022 | PDS Biotechnology Corporation | Post-IPO Debt | 25M |
4/2005 | Intarcia Therapeutics | Debt Financing | 10M |
12/2020 | Corinth MedTech | Debt Financing | 5M |
6/2014 | GenePeeks | Debt Financing | 3M |
6/2018 | Audacy | Debt Financing | 4M |
12/2008 | Tagged | Debt | 5M |
3/2006 | Copan Systems | Series C | 17.5M |
3/2012 | Radisphere Radiology | Debt Financing | 15M |
4/2019 | Encore Dermatology | Debt Financing | 20M |
2/2019 | CSA Medical | Venture Round | 45.2M |
10/2015 | New Haven Pharmaceuticals | Debt Financing | 6.3M |
6/2018 | Audacy | Debt Financing | 4M |
10/2014 | ZetrOZ | Debt Financing | 5M |
7/2022 | Divergent | Private Equity Round | 0 |
12/2022 | Slingshot Aerospace | Debt Financing | - |
1/2018 | Conventus Orthopaedics | Debt Financing | 12M |
6/2014 | Social Intelligence | Debt Financing | - |
1/2021 | Canary Medical | Debt Financing | 20M |
1/2021 | Alula Holdings | Debt Financing | 13M |
5/2020 | Magnolia Medical Technologies | Debt Financing | 20M |
12/2013 | Mederi Therapeutics | Debt Financing | 10M |
12/2021 | IMV Inc | Post-IPO Debt | 25M |
1/2016 | Nomi | Debt Financing | 15M |
2/2021 | Fingerlix | Series C | 0 |
6/2020 | Emalex Biosciences | Debt Financing | 15M |
7/2018 | New Signature | Debt Financing | 15M |
2/2021 | Maverix Platforms | Series C | 0 |
12/2014 | Interleukin Genetics | Post-IPO Debt | 5M |
7/2019 | OutboundEngine | Debt Financing | 8M |
10/2020 | Topia | Debt Financing | 15M |
4/2023 | Unagi Scooters | Debt Financing | 10M |
3/2020 | Castle Creek Biosciences | Debt Financing | 20M |
9/2014 | IntegenX | Debt Financing | 10M |
5/2015 | SilkRoad Technology | Debt Financing | 7.5M |
11/2008 | Revance Therapeutics | Debt Financing | 0 |
7/2018 | MacuLogix | Debt Financing | 10M |
6/2009 | Grab Media | Private Equity Round | 0 |
7/2022 | Nexii | Venture Round | 34.5M |
11/2021 | Everstream Analytics | Debt Financing | 5M |
10/2014 | InVisage Technologies | Debt Financing | - |
6/2018 | Ontrak | Post-IPO Debt | 10M |
11/2020 | Getaround | Debt Financing | 25M |
7/2022 | Divergent | Debt Financing | 80M |
10/2022 | Kodiak Robotics | Debt Financing | 30M |
12/2017 | Aerin Medical | Debt Financing | 15M |
6/2021 | Cerecor | Post-IPO Debt | 20M |
4/2017 | IgnitionOne | Debt Financing | 12M |
8/2016 | Receptiv | Venture Round | 6.5M |
7/2017 | PebblePost | Series B | 15M |
11/2007 | Ambit Biosciences | Series D | 49.3M |
5/2019 | Meditrina, Inc | Debt Financing | 5M |
7/2022 | INBRACE | Debt Financing | 0 |
9/2013 | Inotek Pharmaceuticals | Debt Financing | 0 |
7/2014 | Mblox | Debt Financing | 43.5M |
8/2021 | Nogin | Debt Financing | 15M |
5/2020 | Ceribell | Debt Financing | 20M |
8/2021 | Cerecor | Post-IPO Debt | 10M |
12/2020 | IDbyDNA | Debt Financing | 10M |
3/2016 | Avalanche Technology | Debt Financing | - |
8/2012 | Valore | Debt Financing | 5M |
2/2015 | NinePoint Medical | Debt Financing | 15M |
5/2015 | SavingStar | Debt Financing | 5M |
12/2014 | Palatin Technologies | Post-IPO Debt | 10M |
1/2018 | IntelePeer | Debt Financing | 15M |
4/2015 | ScoreBig | Debt Financing | 7M |
4/2019 | Mustang Bio | Post-IPO Debt | 20M |
11/2020 | Sonex Health | Debt Financing | 7.5M |
9/2014 | Argos Therapeutics | Post-IPO Debt | 25M |
7/2022 | Nexii | Venture Round | 0 |
7/2022 | INBRACE | Debt Financing | 0 |
7/2022 | Divergent | Private Equity Round | 0 |
5/2022 | Soli Organic | Debt Financing | 0 |
3/2022 | Secure Transfusion Services | Debt Financing | 0 |
3/2022 | Aerobiotix | Debt Financing | 0 |
1/2022 | Interior Define | Debt Financing | 0 |
12/2021 | IMV Inc | Post-IPO Debt | 0 |
11/2021 | Everstream Analytics | Debt Financing | 0 |
10/2021 | Stealth BioTherapeutics | Post-IPO Debt | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|